載入...
Development of an orally available inhibitor of CLK1 for skipping a mutated dystrophin exon in Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is a fatal progressive muscle-wasting disease. Various attempts are underway to convert severe DMD to a milder phenotype by modulating the splicing of the dystrophin gene and restoring its expression. In our previous study, we reported TG003, an inhibitor of CDC2-li...
Na minha lista:
發表在: | Sci Rep |
---|---|
Main Authors: | , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Nature Publishing Group
2017
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5448077/ https://ncbi.nlm.nih.gov/pubmed/28555643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep46126 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|